SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-21-000119
Filing Date
2021-08-03
Accepted
2021-08-02 19:56:13
Documents
59
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20210630.htm   iXBRL 10-Q 1622650
2 EX-31.1 lgnd_63021exhibit311.htm EX-31.1 15166
3 EX-31.2 lgnd_63021exhibit312.htm EX-31.2 15399
4 EX-32.1 lgnd_63021exhibit321.htm EX-32.1 11345
10 lgnd-20210630_g1.jpg GRAPHIC 51754
  Complete submission text file 0000886163-21-000119.txt   8119744

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20210630.xsd EX-101.SCH 47379
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20210630_cal.xml EX-101.CAL 91029
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20210630_def.xml EX-101.DEF 294320
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20210630_lab.xml EX-101.LAB 700585
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20210630_pre.xml EX-101.PRE 428967
11 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20210630_htm.xml XML 1476203
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 211137452
SIC: 2834 Pharmaceutical Preparations